Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Бусад хувилбаруудыг харуулах (1)

OBJECTIVES: Reports have suggested that a reduction in tumour 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) examination during or after neoadjuvant chemotherapy may predict pathological response in oesophageal cancer. Our aim was to determine whether metabolic response pr...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Gillies, R, Middleton, MR, Blesing, C, Patel, K, Warner, N, Marshall, R, Maynard, N, Bradley, K, Gleeson, F
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2012

Ижил төстэй зүйлс

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
-н: Gillies, R, зэрэг
Хэвлэсэн: (2012)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
-н: Findlay, J, зэрэг
Хэвлэсэн: (2017)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
-н: Gillies, R, зэрэг
Хэвлэсэн: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
-н: Gillies, R, зэрэг
Хэвлэсэн: (2012)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
-н: Findlay, J, зэрэг
Хэвлэсэн: (2017)

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
-н: Gillies, R, зэрэг
Хэвлэсэн: (2011)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
-н: Gillies, R, зэрэг
Хэвлэсэн: (2011)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
-н: Gillies, R, зэрэг
Хэвлэсэн: (2010)

Predicting pathological response of esophageal cancer to neoadjuvant chemotherapy: the implications of metabolic nodal response for personalised therapy
-н: Findlay, J, зэрэг
Хэвлэсэн: (2016)

Role of adjuvant radiotherapy following neo-adjuvant chemotherapy (NACT) and surgery in oesophageal cancer - a multi-centre retrospective cohort study
-н: Teoh, S, зэрэг
Хэвлэсэн: (2016)

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
-н: Chowdhury, F, зэрэг
Хэвлэсэн: (2008)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
-н: Millo, J, зэрэг
Хэвлэсэн: (2003)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
-н: Findlay, J, зэрэг
Хэвлэсэн: (2016)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
-н: Rana, M, зэрэг
Хэвлэсэн: (2021)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
-н: den Boer, RB, зэрэг
Хэвлэсэн: (2020)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
-н: John M. Findlay, зэрэг
Хэвлэсэн: (2016-04-01)

A reply to evidence-based radiation oncology: oesophagus.
-н: Gillies, R, зэрэг
Хэвлэсэн: (2010)

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma
-н: Kieran G. Foley, зэрэг
Хэвлэсэн: (2021-06-01)

Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival
-н: Teoh, S, зэрэг
Хэвлэсэн: (2018)

Assessment of Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Using MRI and 18F FDG PET/CT
-н: Reem Yusuf AlBuainain, зэрэг
Хэвлэсэн: (2025-01-01)

Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
-н: Tarik Sengoz, зэрэг
Хэвлэсэн: (2023-04-01)

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
-н: Han Wonshik, зэрэг
Хэвлэсэн: (2011-10-01)

PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
-н: Chowdhury, F, зэрэг
Хэвлэсэн: (2009)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
-н: A. G. M. T. Powell, зэрэг
Хэвлэсэн: (2020-08-01)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
-н: Alexander M Th Schmitz, зэрэг
Хэвлэсэн: (2017-01-01)

Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
-н: Lihua Chen, зэрэг
Хэвлэсэн: (2017-08-01)

Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery
-н: Findlay, J, зэрэг
Хэвлэсэн: (2019)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
-н: Turkington, RC, зэрэг
Хэвлэсэн: (2019)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy
-н: M. K. Ibragimova, зэрэг
Хэвлэсэн: (2022-03-01)

Clinical value of SUVpeak-to-tumor centroid distance on FDG PET/CT for predicting neoadjuvant chemotherapy response in patients with breast cancer
-н: Sun-pyo Hong, зэрэг
Хэвлэсэн: (2024-10-01)

Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
-н: Sangwon Han, зэрэг
Хэвлэсэн: (2020-10-01)

Efficacy Of 18FDG-PET/CT In Predicting Response After Neoadjuvant Chemoradiation In Rectal Cancer
-н: Narendra Pandit, зэрэг
Хэвлэсэн: (2023-08-01)

Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer
-н: Inci Kizildag Yirgin, зэрэг
Хэвлэсэн: (2020-01-01)

The Role of Pretreatment 18F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
-н: Yao J, зэрэг
Хэвлэсэн: (2021-10-01)

Predictors of complete response to neoadjuvant chemotherapy in non-metastatic bladder cancer
-н: P. Sousa Passos, зэрэг
Хэвлэсэн: (2020-11-01)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy. Additional material
-н: M. K. Ibragimova, зэрэг
Хэвлэсэн: (2022-03-01)

Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study
-н: Rui-Qin Zhou, зэрэг
Хэвлэсэн: (2023-05-01)

[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
-н: Giulia Polverari, зэрэг
Хэвлэсэн: (2020-10-01)

Correlation Between 18F-FDG PET/CT SUVmax and Clinicopathological Features, Neoadjuvant Chemotherapy Response in Invasive Ductal Breast Carcinoma Patients
-н: LU Shengnan, зэрэг
Хэвлэсэн: (2019-02-01)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
-н: Willard Wong, зэрэг
Хэвлэсэн: (2021-07-01)